fbpx

New data on Lucentis

Novartis, a Swiss multinational pharmaceutical company, recently released new data to support the effectiveness and safety of its flagship ophthalmological drug, Lucentis.

 

At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, recently held in Vienna, Austria, Novartis presented the results from the REPAIR study, conducted over a year on British patients. They show that with an average of 9.7 injections of Lucentis over a five-year period, blindness attributable to AMD could be reduced by 59%.

 

The study also found that visual acuity improved in patients with myopic choroidal neovascularization, with an average of 3.6 injections.

 

Moreover, data from 22 studies support the evidence that the drug is safe, which still needs to be confirmed by a five-year, global study involving 30,000 patients.

 

In 2012, Novartis achieved net sales of $2.4 billion with Lucentis, and Roche, which distributes it in the United States, recorded earnings of $1.56 billion.

Source: http://www.bilan.ch/awp/novartis-presente-de-nouvelles-donnees-sur-lefficacite-du-lucentis-7

Featured Posts

COS Rising Dawn Silhouette

Best of Both Worlds

Launching in 2024, Rising Dawn merges colour science and titanium. With 60s newsroom shapes and Mediterranean-inspired hues, it caters to the nomadic creative.

Learn More
Marchon Eyewear Canada Goose

Marchon Eyewear and Canada Goose Sign Exclusive Licensing Agreement for Eyewear

New sun and optical styles designed under this partnership, the first-ever Canada Goose eyewear collection, will roll out globally starting in North America beginning Spring 2025.

Read more
SILMO Paris 2024

Responsible Company Prize 2024 – Discover the Finalists 

SILMO, in partnership with the HYSSOP agency, has launched the Responsible Company Prize 2024.

Read more
CooperVision

CooperVision Promotes Debbie Olive to Chief Commercial Officer and Rodolphe Rota to President, EMEA

In her new role, Olive will oversee the company’s worldwide commercial functions, driving strategy and growth initiatives across the product portfolio.

Read more
contact lens institute

New Contact Lens Institute™ Research Pinpoints Practice Behaviors that Help Retain New Contact Lens Wearers 

CLI Visionary Panel Previews Latest See Tomorrow Consumer Data at Vision Expo West

Read more
COS Rising Dawn Silhouette

Best of Both Worlds

Launching in 2024, Rising Dawn merges colour science and titanium. With 60s newsroom shapes and Mediterranean-inspired hues, it caters to the nomadic creative.

Learn More
Marchon Eyewear Canada Goose

Marchon Eyewear and Canada Goose Sign Exclusive Licensing Agreement for Eyewear

New sun and optical styles designed under this partnership, the first-ever Canada Goose eyewear collection, will roll out globally starting in North America beginning Spring 2025.

Read More
SILMO Paris 2024

Responsible Company Prize 2024 – Discover the Finalists 

SILMO, in partnership with the HYSSOP agency, has launched the Responsible Company Prize 2024.

Read More
CooperVision

CooperVision Promotes Debbie Olive to Chief Commercial Officer and Rodolphe Rota to President, EMEA

In her new role, Olive will oversee the company’s worldwide commercial functions, driving strategy and growth initiatives across the product portfolio.

Read More
contact lens institute

New Contact Lens Institute™ Research Pinpoints Practice Behaviors that Help Retain New Contact Lens Wearers 

CLI Visionary Panel Previews Latest See Tomorrow Consumer Data at Vision Expo West

Read More
COS Rising Dawn Silhouette

Best of Both Worlds

Launching in 2024, Rising Dawn merges colour science and titanium. With 60s newsroom shapes and Mediterranean-inspired hues, it caters to the nomadic creative.

Learn More
Marchon Eyewear Canada Goose

Marchon Eyewear and Canada Goose Sign Exclusive Licensing Agreement for Eyewear

New sun and optical styles designed under this partnership, the first-ever Canada Goose eyewear collection, will roll out globally starting in North America beginning Spring 2025.

Read more
SILMO Paris 2024

Responsible Company Prize 2024 – Discover the Finalists 

SILMO, in partnership with the HYSSOP agency, has launched the Responsible Company Prize 2024.

Read more
CooperVision

CooperVision Promotes Debbie Olive to Chief Commercial Officer and Rodolphe Rota to President, EMEA

In her new role, Olive will oversee the company’s worldwide commercial functions, driving strategy and growth initiatives across the product portfolio.

Read more
contact lens institute

New Contact Lens Institute™ Research Pinpoints Practice Behaviors that Help Retain New Contact Lens Wearers 

CLI Visionary Panel Previews Latest See Tomorrow Consumer Data at Vision Expo West

Read more
COS Rising Dawn Silhouette

Best of Both Worlds

Launching in 2024, Rising Dawn merges colour science and titanium. With 60s newsroom shapes and Mediterranean-inspired hues, it caters to the nomadic creative.

Learn More
Marchon Eyewear Canada Goose

Marchon Eyewear and Canada Goose Sign Exclusive Licensing Agreement for Eyewear

New sun and optical styles designed under this partnership, the first-ever Canada Goose eyewear collection, will roll out globally starting in North America beginning Spring 2025.

Read more
SILMO Paris 2024

Responsible Company Prize 2024 – Discover the Finalists 

SILMO, in partnership with the HYSSOP agency, has launched the Responsible Company Prize 2024.

Read more
CooperVision

CooperVision Promotes Debbie Olive to Chief Commercial Officer and Rodolphe Rota to President, EMEA

In her new role, Olive will oversee the company’s worldwide commercial functions, driving strategy and growth initiatives across the product portfolio.

Read more
contact lens institute

New Contact Lens Institute™ Research Pinpoints Practice Behaviors that Help Retain New Contact Lens Wearers 

CLI Visionary Panel Previews Latest See Tomorrow Consumer Data at Vision Expo West

Read more